Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]
Conflict of interest BS has previously received financial support from Natural Alternatives International (NAI), a company that produces BA, to undertake a study unrelated to this review
Concerning the effect of combining VitC with other (chemo-) therapies, an LC-MS/MS study in breast cancer cell line MCF7 cell line [167] showed that combining topoisomerase II inhibitor doxorubicin with medium dose (200 M) VitC lead to a down-regulation of ribosomal, transcriptional and translational, as well and anti-oxidant (eg
Mullen, P
That is a reason the research literature treats active cancer as an important consideration, and a reason this is a compound to understand thoroughly rather than treat casually
Rather than trying to estimate the amount that's left, it's always safest to speak with your prescribing healthcare provider or pharmacist before using any remaining medication
